Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
12 May 2015
IN THIS ISSUE
News
Webcasts
Events
About Us
Featured Content
Modern Manufacturing Systems Key to FDA Quality Initiative
More reliable operations would accelerate product development and prevent drug shortages. More...
 
Designing Trouble-Free Freeze-Drying Processes
Efficient freeze-drying processes result in time and energy savings, reduced failure rates, and improved batch consistency. More...
 
Drug Discovery and Development in India
Hope abounds for local drug discovery companies despite challenges at home. More...
 

 
Top Stories
Novartis Announces EU Approval of Lung Cancer Drug
Novartis announces that its lung cancer drug, Zykadia, gained European Union approval. More...
 
Alexion Acquires Synageva for $8.4 Billion
Alexion announces it will expand its rare disease pipeline with a definitive agreement to acquire Synageva. More...
 
Court Blocks First FDA-Approved Biosimilar, for the Time Being
The US Court of Appeals granted Amgen's request to block Novartis' Neupogenbiosimilar, Zarxio, from the US market until the court resolves litigation between the two companies. More...
 
Industry News
J&J Announces Compassionate Care Committee in Collaboration with NYU
Johnson & Johnson announces partnership with NYU School of Medicine to launch a compassionate care committee for individual patient requests of investigational drugs. More...
 
Biosimilar Giants Launch Biosimilars Forum
Eleven of the leading US biosimilar developers have collaborated to form the Biosimilars Forum, a nonprofit organization formed to expand patient access to biosimilars. More...
 
CPhI Worldwide Launches Charity Initiative with Global Angels
A range of packages is available for industry partners to implement charity giving. More...
 
Teva Parenteral Medicines Recalls Adrucil
The company voluntarily recalls select lots of Adrucil due to particulate matter. More...
 
BASF Shifts Focus to Excipients
BASF announces that it will sell its custom synthesis business and parts of its API business to focus its expertise on pharmaceutical excipients. More...
 
Biosimilars Will Bring Significant Litigation and Patent Challenges
Intellectual property lawyers estimate biosimilar litigation will swell as early as 2018. More...
 
Novo Nordisk Invests DKK1.5 Billion in New Manufacturing Facility
Novo Nordisk announces that it will invest DKK1.5 billion (US$224 million) in a haemophilia treatment manufacturing facility in Denmark. More...
 
Bayer Buys Rights to Isis Pharma's Blood Thinner for Up to $155 Million
Bayer announces that it will pay up to $155 million, plus royalties, for the rights to Isis Pharma's anti-clotting drug, ISIS-FXI. More...
 
Webcasts
Practical Guidance for Successful Mammalian Cell Banking & Cell Line Characterization
Thursday, May 14, 2015, 11 am EDT/8 am PDT/16:00 BST/17:00 CEST
Sponsored by Eurofins Lancaster Laboratories
 
Stability Assessment for Shipment of API and Drug Products
Thursday, May 21, 2015, 11 am EDT
Sponsored by Patheon
 
The Importance of Data Integrity in a GXP Regulated Laboratory
Wednesday, May 27, 2015 at 11AM ET
Sponsored by Mettler Toledo
 
More Webcasts

Product/Service Profiles
ABITEC Corporation

CAPMUL® — Where Formulation Begins™
ABITEC’s CAPMUL bioavailability enhancers are medium-chain mono- and di-glycerides and propylene glycol esters. These functional lipid excipients act as solubilizers and emulsifiers in oral, topical, transdermal, and parenteral drug delivery systems.
Read more
Adare Pharmaceuticals, Inc.

New possibilities in taste masking
By understanding patient needs, Adare Pharmaceuticals provides enhanced medicines, creating new possibilities for improved patient health. Our innovative Microcaps® Taste Masking Technology can help address the issue of taste acceptability.
Read more
Albany Molecular Research Inc.

AMRI Glasgow Ltd. is located in the United Kingdom. The site provides pre-formulation, formulation and process development services, as well as manufacture of sterile products for clinical trials.
Read more
EtQ

The Life Sciences Guidebook: Selecting, Implementing, and Using FDA Compliance Software Solutions
In a market where high-demand causes organizations to seek software systems that will fit into their complex business infrastructure, the pressure to find the right system often causes angst to many. Learn some key elements to spotting a good FDA Compliance solution, techniques for achieving GMP Compliance, and how to ensure that Quality and Compliance are met in the Life Science industry.
Read more
LB Bohle

Bohle Coating – Bohle Film Coater BFC
The BFC is the high-end version of the Bohle coater designed specifically for high speed, problem-free coating, providing unparalleled tablet uniformity and efficiencies. A high containment execution is also available.
Read more

Event Profile
CPhI Istanbul 2015 - The Leading Pharma Event in Eurasia

Date: 3rd - 5th June 2015
Venue: Istanbul Congress Center, ICC
CPhI Istanbul and co-located events P-MEC, InnoPack and ICSE will bring together local Turkish and regional (the Balkans, Central Asia, Middle East and North Africa) drug manufacturers with global suppliers of raw materials, machinery, packaging solutions and contract services (4 events under 1 roof).
Read more
 

Reference Library

Pharmaceutical Technology Solid Dosage Combo
Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid-dosage form principles such as oral solid-dosage forms, powders, mixing and blending, excipients, tableting, and coating. Drug delivery system manufacturing professionals can use the solid dosage manufacturing books to stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development. ... Click here

Contact Us

Click here to contact editorial.

Click here to contact sales.